Key result
Hematology-guided factor VIII replacement and aspirin enable safe angiography in high-risk MINOCA with hemophilia.
Why the study?
Improved survival in hemophilia has increased exposure to atherosclerotic cardiovascular disease, where acute coronary syndromes pose complex therapeutic challenges requiring a balance between ischemic and hemorrhagic risks.
Case Report (n=1)
Management of acute coronary syndrome in patients with hemophilia requires individualized, multidisciplinary balancing of thrombotic and bleeding risks, including factor replacement and tailored antithrombotic strategies.
Answers are grounded in this paper and cite their sources.
Requires individualized bleeding-thrombotic risk assessment in hemophilia with ACS; leaves open standardized protocols pending higher-level evidence.
BACKGROUND: Improved survival in patients with hemophilia has resulted in an aging population increasingly exposed to atherosclerotic cardiovascular disease. Acute coronary syndromes pose complex therapeutic challenges because ischemic and hemorrhagic risks must be balanced. CASE SUMMARY: An 82-year-old man with partial factor VIII deficiency presented with high-risk non-ST-segment elevation myocardial infarction. After hematology-guided factor VIII replacement, coronary angiography showed nonobstructive atheromatosis, supporting a working diagnosis of myocardial infarction with nonobstructive coronary arteries. Cardiac magnetic resonance was declined because of claustrophobia. In the absence of stent implantation, aspirin monotherapy was selected. REVIEW SUMMARY: This review addresses factor replacement, antithrombotic and revascularization strategies, evaluation of myocardial infarction with nonobstructive coronary arteries, and emerging hemophilia therapies. TAKE-HOME MESSAGE: Management of acute coronary syndrome in hemophilia requires individualized, multidisciplinary balancing of thrombotic and bleeding risks.
No takes yet. Share an insight, caveat, or question.
Cieri et al. (2026) conducted a case report in Acute coronary syndrome (MINOCA) and partial factor VIII deficiency (hemophilia) (n=1). Hematology-guided factor VIII replacement and aspirin monotherapy was evaluated. Hematology-guided factor VIII replacement and aspirin monotherapy enabled safe angiography and management of high-risk NSTEMI (MINOCA) in an 82-year-old man with partial factor VIII deficiency.
Synapse has enriched 10 related papers. Consider them for comparative context: